Email
Password

Forgot Password?


Available Now

Course Overview

The NLA's Foundations of Lipidology Course provides a comprehensive, in-depth indoctrination to lipid science and is open to all health care professionals interested in developing a core competency in the diagnosis and treatment of dyslipidemia. The interactive Lipid Academy course provides health professionals with the knowledge and tools necessary to work effectively in a lipid practice, and will serve as a preparatory course for the Annual Scientific Forum and other advanced lipid training.

This version of the NLA Foundations of Lipidology is offered as a 10-hour online course.

Course Curriculum

  • Lipids, Lipoproteins and Atherosclerosis
  • Landmark Clinical Trials
  • Diagnosis and Clinical Appraisal
  • Pharmacologic Therapies
  • Overview of Clinical Guidelines in Lipid Management
  • Therapeutic Lifestyle Changes

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advance practice registered nurses, nurse practitioners and registered dietitians with an interest in lipid management.

Objectives and Accreditation

ACTIVITY DATES

Release Date: October 22, 2018
Expiration Date: October 22, 2021

FEE INFORMATION

This course offered to NLA members at a cost of $550.
All other participants may purchase this course at a cost of $950.

PROGRAM OVERVIEW

The NLA's Foundations of Lipidology course, formerly Lipid Academy, provides an introductory review of the core curriculum in Clinical Lipidology. This course is designed for any healthcare professional seeking to learn the fundamentals of Lipidology. Experts in Lipidology will lecture on basic concepts and guide participants through interactive learning scenarios that provide the knowledge and tools necessary to work effectively in a lipid practice and prepare for advanced training.

This course is particularly useful to review core elements of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacist, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

ACTIVITY TYPE

Enduring Internet Activity

TARGET AUDIENCE

This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advance practice registered nurses, nurse practitioners and registered dietitians with expertise in Lipidology looking for further advanced training.

LEARNING OBJECTIVES

At the conclusion of this activity, participants should be able to:

  • Explain the pathogenesis of atherosclerosis, including the role of inflammation.
  • Describe the functions and sources of cholesterol and triglycerides including the role of lipoproteins in atherosclerosis.
  • Review basic principles of statistics in clinical trials.
  • Discuss key clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention.
  • Appraise clinical trial design and methods in published literature.
  • Recognize the role of drug therapy in the management of dyslipidemia.
  • Review the mechanism of action, pharmacokinetics, and efficacy of approved drugs for the management of dyslipidemia.
  • Council patients on dietary recommendation for lipid management.
  • Recognize the importance of lifestyle modification in the reduction of cardiometabolic risk.
  • Compose a treatment plan for patients with complex lipid disorders.
  • Describe treatment approaches for dyslipidemia in specific populations based on age, gender, ethnicity, and cultural variables.
  • Discuss current guidelines for the management and treatment of patients with dyslipidemia.
  • Identify primary and secondary causes of dyslipidemia.
  • Compose a treatment plan for the management of dyslipidemia in specific populations.
  • Compose a treatment plan for reducing risk of CVD in patients with dyslipidemia.
  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

CRITERIA FOR SUCCESS

Statements of credit will be awarded based on the participant's completion of the activity materials and submission of the activity evaluation form. A statement of credit will be available for download upon completion of the online evaluation/claimed credit form. In order to receive credit, participants should complete the online course, score at least 70% on the post-test, and submit the evaluation. The deadline to claim credit is October 22, 2021.
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
Estimated Time for Completion: 11.75 hours

COMMERCIAL SUPPORT

There is no commercial support provided for this activity.

CREDIT DESIGNATION

abim Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.75 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Jointly Accredited Provider

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this Enduring Internet activity for a maximum of 11.75 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 11.50 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.

Pharmacists
Accreditation Council for Pharmacy EducationUniversal Activity Number – JA0007192-0000-18-027-H01-P (Application)
This Activity has been approved for 11.75 contact hour(s) (1.175 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
The maximum number of hours awarded for this CE activity is 11.7 contact hours.

For the advanced practice nurse, this activity has 2.8 contact hours of pharmacotherapy content.

FACULTY

Program Chair
Joseph J. Saseen, PharmD, BCPS, BCACP, FNLA**

Professor and Vice Chair, Department
of Clinical Pharmacy
Professor, Department of Family Medicine
University of Colorado Anschutz Medical Campus
Aurora, CO

Program Chair
Daniel E. Soffer, MD, FNLA*

University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA

Lori Alexander, MSHS, RD, CCRC, FNLA**
Site Manager
St. Johns Center for Clinical Research
Ponte Vedra, FL

Ann Liebeskind, MD*
Mobile Health Team
Neenah & Wauwautosa, WI

Pamela B. Morris, MD, FNLA*
Director, Preventive Cardiology
Co‐Director, Women’s Heart Care
Medical University of South Carolina
Charleston, SC


*Denotes Diplomate, American Board of Clinical Lipidology (ABCL)
**Denotes Diplomate, Accreditation Council for Clinical Lipidology

DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLOSURE DECLARATION

It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose.

DISCLAIMER

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader's misunderstanding of content.

PERMISSIONS

The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.

Faculty Financial Disclosures

Speaker
Relationship
Company

Alexander, Lori
N/A
Nothing to Disclose

Liebeskind, Ann
N/A
Nothing to Disclose

Morris, Pamela
Advisory Board
Amgen, Sanofi Regeneron
Steering Committee
Amgen, Esperion

Saseen, Joseph
N/A
Nothing to Disclose

Soffer, Daniel
Advisory Board
Akcea
Contracted Research
Akcea, Amgen, AstraZeneca, Esperion, Ionis Pharmaceuticals, Kowa, Novartis, Regeneron, Regenex, Sanofi
Speakers Bureau
Sanofi

Planner Financial Disclosures

NLA
N/A
The National Lipid Association Staff has nothing to disclose

Dixon, Dave
N/A
Nothing to Disclose

Goldenberg, Edward
Speaker
Amarin, Amgen, Regeneron

Hemphill, Linda
Contracted Research
IONIS, Regeneron Sanofi
Consultant
Amgen, Regeneron

White Thomas
Speaker
Amarin, IONIS, Janssen


Please enter your business email address. We will email you a link that will allow you to select a new password.

Please enter your business email address to start your registration.